The limiting factor for the future of therapeutics is trust. Without addressing the issue of underrepresentation in clinical trials, we risk developing therapeutics that perpetuate existing disparities in healthcare. Historical violations and abuses, such as the infamous Tuskegee Study, have left a deep-seated distrust of clinical trials among communities that have been historically marginalized.

As healthcare continues its transformation towards personalized and precision medicine, the potential for these disparities to widen faster than ever becomes a pressing concern. If left unaddressed, this could exacerbate the already existing gaps in access to innovative treatments and medical advancements.

In this session, we will bring together thought leaders, healthcare professionals, and community advocates to engage in a candid conversation about the importance of rebuilding trust in the healthcare system. Together, we will explore strategies to increase representation in clinical trials, foster transparency, and prioritize ethics to ensure that the future of therapeutics is more equitable and inclusive.

Join us to discover how we can collectively work towards bridging the trust gap and fostering a future of therapeutics that empowers all communities and leaves no one behind.